Table 2.

Cost savings and utility gains of the test strategy compared with the usual care strategy for different adherence assumptions for 1000 patients

Adherence rate, %	Cost saving (loss), $	QALYs gained
1	(72,332)	0.7
2	(55,331)	1.1
3	(38,330)	1.5
4	(21,329)	2.0
5	(4,328)	2.4
7.5	38,175	3.5
10	80,678	4.5
15	165,683	6.7
20	250,689	8.8
25	335,694	11.0
30	420,699	13.1
40	590,710	17.5
50	760,721	21.8